Format

Send to:

Choose Destination
See comment in PubMed Commons below
Br J Psychiatry. 1992 Nov;161:665-70.

Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial.

Author information

  • 1Department of Psychiatry, Hospital de Prínceps d'Espanya, Barcelona, Spain.

Abstract

A double-blind clinical trial of clomipramine versus phenelzine was carried out on 30 patients suffering from DSM-III obsessive-compulsive disorder. The study period was 12 weeks, and the maximum doses used (from the fifth week on) were 225 mg/day for clomipramine (14 patients) and 75 mg/day for phenelzine (12 patients); four patients dropped out. Obsessive symptoms improved significantly in both drug groups, but there was no significant difference between groups. Depressive symptoms improved before obsessive ones.

PMID:
1422616
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk